Inflammatory breast cancer: new hopes and many hurdles.
Rowan
Karen
K
D001741:Black or African American / Q000706:statistics & numerical data*; D000818:Animals; D014408:Biomarkers, Tumor / Q000378:metabolism*; D001943:Breast Neoplasms / Q000201:enzymology / Q000453:epidemiology / Q000378:metabolism* / Q000473:pathology*; D055511:CCN Intercellular Signaling Proteins; D002401:Cathepsin B / Q000378:metabolism; D045744:Cell Line, Tumor; D018450:Disease Progression; D015536:Down-Regulation; D039603:Eukaryotic Initiation Factor-4G / Q000378:metabolism; D005260:Female; D015972:Gene Expression Regulation, Neoplastic; D006801:Humans; D007249:Inflammation; D018969:Insulin-Like Growth Factor Binding Proteins / Q000378:metabolism; D008207:Lymphatic Metastasis; D014481:United States / Q000453:epidemiology; D015854:Up-Regulation; D020741:rho GTP-Binding Proteins / Q000378:metabolism; D000075024:rhoC GTP-Binding Protein
D014408:Biomarkers, Tumor; D055511:CCN Intercellular Signaling Proteins; C400081:CCN6 protein, human; C113920:EIF4G1 protein, human; D039603:Eukaryotic Initiation Factor-4G; D018969:Insulin-Like Growth Factor Binding Proteins; D002401:Cathepsin B; C066690:RHOC protein, human; D020741:rho GTP-Binding Proteins; D000075024:rhoC GTP-Binding Protein